DiaCarta Reports Positive Clinical Trial Data For Its Blood Based Test to Triage FIT-Positive Patients Enrolled in CRC Screening Programs

Posted on by

PLEASANTON, Calif., Jan. 3, 2025 /PRNewswire/ — DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical test)-positive patients in colorectal cancer (CRC)…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.